Search Browse Earnings

Vera Therapeutics, Inc. — SlamSEC

Vera Therapeutics, Inc.

Nasdaq:VERA

Pharmaceutical Preparations·BRISBANE, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$102.0M

FY 2025

Net Income

-$96.0M

FY 2025

EPS (Diluted)

-$2.25

FY 2025

Stock Price

$38.94

-0.4%

2026-03-09

52W Range

$18.53 – $56.05

P/E Ratio

-17.3x

Market Cap

$2.5B

Cash

$92.6M

FY 2025

Total Debt

$50.7M

FY 2025

Net Cash

$42.0M

FY 2025

Enterprise Value

$2.4B

Debt / EBITDA

0.4x

FY 2025

EV / EBITDA

-24.0x

Employees

—